Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fortress Biotech

1.52
+0.0000
Post-market: 1.47-0.0500-3.29%18:06 EDT
Volume:281.88K
Turnover:418.19K
Market Cap:44.89M
PE:-0.45
High:1.55
Open:1.50
Low:1.44
Close:1.52
Loading ...
Apr 28, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 23, 2020

Major Issues Report

8-K - Current report
Mar 16, 2020

Major Issues Report

8-K - Current report
Mar 16, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Feb 12, 2020

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Jan 27, 2020

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 31, 2019

Major Issues Report

Current report, item 5.02
Nov 26, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 26, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Nov 22, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 12, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 12, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 12, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 12, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 19, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Aug 09, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 09, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]